New drug duo aims to tame Hard-to-Treat blood cancer
NCT ID NCT06645678
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study tests whether combining two medicines, mezigdomide and elranatamab, can shrink tumors or slow disease in people with multiple myeloma that has come back or stopped responding to other treatments. About 75 adults will take part. The goal is to see how many patients achieve at least a partial response, and how long they stay progression-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center, University of Ulsan College of Medicine
RECRUITINGSeoul, South Korea
-
Chonnam National University Hwasun Hospital
RECRUITINGHwasun, South Korea
-
National University Hospital (NUH)
RECRUITINGSingapore, Singapore
Contact
-
Samsung Medical Center, Sungkyunkwan University School of Medicine
RECRUITINGSeoul, South Korea
-
Seoul National University Hospital
NOT_YET_RECRUITINGSeoul, South Korea
-
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
RECRUITINGSeoul, South Korea
-
Singhealth Duke NUS blood cancer center
RECRUITINGSingapore, Singapore
Contact
Conditions
Explore the condition pages connected to this study.